Introduction {#s1}
============

Eukaryotic messenger RNA (mRNA) must be processed prior to programming protein synthesis. The minimal modifications for most mRNAs include capping, pre-mRNA splicing and polyadenylation [@pone.0003369-Komili1]. These reactions occur in the nucleus and must be completed prior to nuclear export of the mRNA to the cytoplasm. The cytoplasmic fate of mRNA is also subject to regulation at the level of localization, stability and translational efficiency [@pone.0003369-Sonenberg1]. RNA processing reactions have been extensively studied using biochemical systems; however, these are functionally linked in living cells providing increased efficiency and regulatory potential for gene expression [@pone.0003369-Maniatis1]. The molecular mechanisms responsible for the coupling of post-transcriptional regulatory networks are poorly understood. A subset of multi-functional mRNA binding proteins operating at the interface of distinct RNA processing machineries may contribute to coupling of post-transcriptional gene expression.

The Serine and Arginine-rich (SR) protein family consists of eight phylogenetically conserved proteins ranging in molecular weight from 20--75 kDa. SR proteins have well-characterized roles in pre-mRNA splicing including exon definition and assembly of the mature spliceosome [@pone.0003369-Hastings1], [@pone.0003369-Ram1]. A subset of the SR protein family also function outside pre-mRNA splicing [@pone.0003369-Huang1]. Indeed, we recently established a role of the shuttling SR protein SF2/ASF in mRNA translation [@pone.0003369-Sanford1], [@pone.0003369-Sanford2]. SF2/ASF enhances translation initiation by promoting phosphorylation of the translational repressor protein 4E-BP1 by the mammalian target of rapamycin (mTOR) [@pone.0003369-Michlewski1]. Further roles for SRp20 and 9G8 in internal ribosome entry site (IRES)-mediated translation and intronless mRNA export have been documented [@pone.0003369-Bedard1], [@pone.0003369-Huang2]. These observations suggest the hypothesis that shuttling SR proteins may couple nuclear and cytoplasmic steps of pre-mRNA processing. Elucidating endogenous mRNA targets that are regulated by SF2/ASF in both the nucleus and cytoplasm is critical to testing the validity of this hypothesis.

The cross-linking immunoprecipitation (CLIP) method is a powerful method for elucidating the target specificity of RNA binding proteins *in vivo* [@pone.0003369-Ule1]. In this protocol, living cells are exposed to UV irradiation to induce covalent cross-links between RNA binding proteins and their *in situ* RNA targets. Prior to immunoprecipitation of a specific RNA binding protein lysates are treated with RNase in order to generate 40--60 nt cross-linked RNA tags. Co-purifying RNA tags are then cloned and sequenced revealing genomic locus of the RNA as well as the position of the RNA-protein interaction within the RNA molecule. CLIP analysis of the neural specific splicing factor Nova identified a post-transcriptional regulatory network related to synaptic function. Mechanistic studies determined the relationship between positions of Nova binding sites and effects on splice site selection [@pone.0003369-Ule2], [@pone.0003369-Ule3]. These data were used to build an RNA map capable of predicting Nova-dependent splice site selection [@pone.0003369-Ule4]. Here, we use CLIP to identify RNA targets for the shuttling SR protein, SF2/ASF, in order to test the hypothesis that this SR family protein member regulates nuclear and cytoplasmic expression of specific mRNAs in living cells. This sampling of nuclear, cytoplasmic and polyribosome-associated mRNA targets suggests that SF2/ASF may remain associated with a subset of specific transcripts as they are trafficked from the nucleus to the cytoplasm. Furthermore we provide evidence that SF2/ASF couples alternative splicing with enhanced translation for several endogenous mRNAs. These data provide insights to the targets and roles of an essential shuttling RNA binding protein in coupling nuclear and cytoplasmic steps of post-transcriptional gene expression.

Results {#s2}
=======

Cross-linking immunoprecipitation of SF2/ASF {#s2a}
--------------------------------------------

Previously, we have shown that SF2/ASF binds directly to cytoplasmic mRNA *in vivo* and enhances the translation of reporter mRNAs both *in vitro* and *in vivo* [@pone.0003369-Sanford2], suggesting that SF2/ASF may regulate the nuclear and cytoplasmic fate of specific endogenous mRNAs. Despite nearly two decades of study, few endogenous targets of SR proteins have been identified. In order to determine if SF2/ASF can regulate nuclear and cytoplasmic processing of endogenous mRNAs we used the CLIP protocol to identify binding sites for SF2/ASF in mRNAs from different subcellular fractions. Nuclear, cytoplasmic and polyribosome-containing sub-cellular fractions were prepared as previously described [@pone.0003369-Sanford1] from control cells or those exposed to UV irradiation and cell extracts were treated with decreasing amounts of RNase A/T1 to partially degrade cross-linked RNA molecules. SF2/ASF was immunoprecipitated from each extract under stringent conditions. Purified SF2/ASF-RNA complexes were modified on beads by the addition of a 3′ RNA linker and ^32^P at the 5′ end. Complexes were resolved on 10% Novex Nupage gels (Invitrogen, USA) and transferred to nitrocellulose. [Fig. 1](#pone-0003369-g001){ref-type="fig"} shows UV-dependent, RNase-sensitive complexes immunoprecipitated by the anti-SF2/ASF monoclonal antibody. Note the increased molecular weight of the complex as RNase concentrations are decreased. The heterogeneous migration of these complexes is due to increasing length of captured RNA fragments. Complexes between 37 and 42 kDa were purified from nitrocellulose membranes. RNA was extracted, ligated to a 5′ RNA linker and amplified by RT-PCR (not shown). Amplicons were then concatamerized, ligated in pcDNA3.1, cloned and sequenced.

![Cross-linking immunoprecipitation of SF2/ASF from different HEK293T cellular fractions.\
SF2/ASF-RNA complexes, indicated by the bracket, were visualized by autoradiography. Positions of molecular weight standards are given at the left of each panel and exposure of cells to ultra violet radiation (UV) is indicated by + or −.](pone.0003369.g001){#pone-0003369-g001}

Mapping of SF2/ASF mRNA targets {#s2b}
-------------------------------

We obtained sequences from more than 3,500 amplicons corresponding to putative SF2/ASF RNA targets. We used BLAT to align sequences to the human genome allowing for two mis-matches or gaps within the alignment [@pone.0003369-Kent1]. For this analysis we focused on RNA fragments corresponding to protein coding genes, any other sites were ignored. 1,237 amplicons could be mapped to a total of 326 positions in 180 protein coding genes; 43% of the binding sites were represented by multiple sequences. A majority of binding sites (68%) fell within exonic sequences ([Fig. 2A](#pone-0003369-g002){ref-type="fig"}). We also detected binding sites for SF2/ASF within intronic sequences. However, as shown below, we were unable to detect a consensus motif within the pool of intronic binding sites, therefore we focused the remaining analysis on the exonic pool of sequences. We compared the binding specificity of SF2/ASF RNA targets identified in different sub-cellular compartments in order to determine if any RNA transcripts were in common. We found that 72 exonic binding sites are engaged by SF2/ASF in both the nucleus and the cytoplasm or polysome fraction. Interestingly, 15 binding sites in 12 different genes are engaged by SF2/ASF in all three compartments ([Fig. 2B](#pone-0003369-g002){ref-type="fig"}). These data provide strong evidence that SF2/ASF associates with a subset of messenger RNAs in the nucleus and that the same *cis*-acting element is recognized in the cytoplasm. We hypothesize that SF2/ASF remains bound to the mRNA as the mRNA is trafficked from the nucleus to the cytoplasm [@pone.0003369-Sanford1].

![Distribution of SF2/ASF binding sites in relation to gene structure and sub-cellular localization.\
A) The "coding" SF2/ASF CLIP tags from nuclear, cytoplasmic and polysomal sets were analyzed in relation to their relative position within genes. This showed that the majority map to intronic or to coding exonic sequences and only a small proportion mapped to UTRs. B) Venn diagram of exonic SF2/ASF binding sites from Nuclear, cytoplasmic and polysomal sub-cellular fractions. The number of unique binding sites identified in each fraction is designated as "n".](pone.0003369.g002){#pone-0003369-g002}

Identification of a consensus binding site for SF2/ASF {#s2c}
------------------------------------------------------

The *in vitro* RNA binding specificity of many SR proteins including SF2/ASF, have been well-characterized using approaches such as selected evolution of ligands by exponential enrichment (SELEX) [@pone.0003369-Tuerk1]. Different consensus sites for SF2/ASF have been obtained using different SELEX strategies [@pone.0003369-Smith1], [@pone.0003369-Tacke1]. We used the motif finding algorithm MEME, to search exonic or intronic RNA fragments for over represented sequences [@pone.0003369-Bailey1], [@pone.0003369-Bailey2]. [Fig. 3A](#pone-0003369-g003){ref-type="fig"} shows that a purine-rich consensus motif is present within exonic sequences targeted by SF2/ASF with a highly significant expectation value (e value) of 3.8×10^−4^. No other statistically significant motifs were identified within the exonic sequences. By contrast MEME was unable to detect an enriched sequence motif within the intronic pool of binding sites identified by CLIP. These data suggest that intronic binding sites may prove to be a nonspecific contaminant. To test the validity of the consensus model, we asked if the consensus sequence is enriched in exonic or intronic sequences across the genome using composite exons [@pone.0003369-Smith1]. We then used the position weight matrix calculated from the consensus motif to determine the number of binding sites at each position across all intron/exon/intron composite sequences. [Fig. 3B](#pone-0003369-g003){ref-type="fig"} demonstrates that the consensus motif for SF2/ASF is highly enriched at the edges of exons relative to intronic sequences or the interior of exon sequences. These data support the hypothesis that SF2/ASF plays a role in the establishment of exon identity.

![Identification of the SF2/ASF consensus binding site and its frequency distribution in coding exons and flanking introns.\
A) The exonic or intronic clip tags were analyzed using MEME to identify sequence patterns that are over-represented. MEME was unable to identify a consensus motif within the intronic binding sites. B) This pattern was used to analyze composite sequences made for all exons with more than 100 nucleotides, from protein coding genes. This analysis shows that the pattern is over-represented within exonic sequences and in particular within the exon 5′ prime and middle of the exons.](pone.0003369.g003){#pone-0003369-g003}

Annotation of alternatively spliced pre-mRNA targets of SF2/ASF {#s2d}
---------------------------------------------------------------

SR proteins have well characterized roles in both constitutive and alternative pre-mRNA splicing. Resolving these dual functions of SR proteins solely by the use of heterologous substrates and mini-gene reporters has proven difficult. In order to determine if the endogenous binding sites for SF2/ASF may reveal any clues to the roles of SR proteins in alternative splicing we manually curated annotated ENSEMBL transcripts targeted by SF2/ASF for examples of alternative splicing using two distinct databases: AceView and FAST-DB [@pone.0003369-delaGrange1], [@pone.0003369-ThierryMieg1]. Of the 234 exonic binding sites identified by CLIP, only 72 were subject to some form of alternative processing ([Table 1](#pone-0003369-t001){ref-type="table"}--[](#pone-0003369-t002){ref-type="table"} [](#pone-0003369-t003){ref-type="table"} [4](#pone-0003369-t004){ref-type="table"} for details on binding sites associated with specific types of alternative splicing). We also identified 9 binding sites within constitutive exons located downstream and adjacent to alternative cassette exons (See [Table 5](#pone-0003369-t005){ref-type="table"}). This type of arrangement suggests that SF2/ASF may promote skipping of the upstream cassette exon, as recently demonstrated for alternative splicing of the receptor tyrosine kinase RON during breast cancer metastasis [@pone.0003369-Ghigna1]. Within this list of alternative exons targeted by SF2/ASF there is a modest enrichment for genes encoding RNA binding proteins (SFRS1, PABPC1, hnRNPDL, hnRNPAB, SERBP1, RPL5, SON, RPL0, RPS10, RPL12, RPS24, RPL19, PKRA) and genes involved in regulation of biological processes such as cell division, proliferation and apoptosis (CDK4, MAPK3, ACIN1). The ENSA gene is also of interest as it is bound by SF2/ASF in each sub-cellular compartment and is a Type 2 diabetes candidate gene. ENSA is an endogenous ligand for the sulfonylurea receptor which plays an important role in insulin release from pancreatic beta cells [@pone.0003369-DrummondBarbosa1], [@pone.0003369-Wang1]. Several of the alternative splicing events involving exons targeted by SF2/ASF lead to premature termination codons and potentially NMD (SFRS1, CDK4, MAPK3, for example) however the majority of alternative events alter the primary structure of the encoded polypeptide (not shown). All of these splicing events can be visualized using the Friendly Alternative Splicing and Transcript Diversity database (<http://www.fast-db.com>; [@pone.0003369-delaGrange1]).

10.1371/journal.pone.0003369.t001

###### Annotation of alternative cassette exons bound by SF2/ASF.

![](pone.0003369.t001){#pone-0003369-t001-1}

  *Partial list of alternative cassette exons bound by SF2/ASF*                                                                                                                                                         
  --------------------------------------------------------------- ---- --------------------------------------------------------------------------------------- ------------------------------ ------------------------- ----------------------------------------------------------------------
  ACIN1                                                            12                        apoptotic chromatin condensation inducer 1                                   Nucleus                      enzyme                             apoptotic chromosome condensation
  BECN1                                                            11               beclin 1 (coiled-coil, myosin-like BCL2 interacting protein)                     Nucleus; Polysome                  other                          anti-apoptosis;cellular defense response
  CALM2                                                            4                         calmodulin 2 (phosphorylase kinase, delta)                                  Cytoplasm                      other            Calcium Binding;G-protein coupled receptor protein signaling pathway
  DHX15                                                            5                          DEAH (Asp-Glu-Ala-His) box polypeptide 15                                  Cytoplasm                     enzyme                                      mRNA processing
  ERCC6                                                            2    excision repair cross-complementing rodent repair deficiency, complementation group 6            Cytoplasm             transcription regulator             transcription-coupled nucleotide-excision repair
  MAPK3                                                            6                             mitogen-activated protein kinase 3                                      Cytoplasm                     kinase                              intracellular signaling cascade
  NUP43                                                            4                                      nucleoporin 43kDa                                     Nucleus; Cytoplasm; Polysome         transporter                                   nuclear envelope
  PIP5K2A                                                          7                  phosphatidylinositol-5-phosphate 4-kinase, type II, alpha                           Nucleus                      kinase                           glycerophospholipid metabolic process
  SON                                                              3                                   SON DNA binding protein                                            Nucleus                       other                                       anti-apoptosis
  TCF12                                                            9          transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)                   Cytoplasm             transcription regulator       regulation of transcription from RNA polymerase II promoter
  WDR42A                                                           11                                   WD repeat domain 42A                                         Nucleus; Cytoplasm                 other                                          Unknown
  Y13871                                                           1                               hypothetical protein LOC202181                               Nucleus; Cytoplasm; Polysome            other                                          Unknown
  ZHX1                                                             3                                zinc fingers and homeoboxes 1                                         Nucleus              transcription regulator           negative regulation of transcription, DNA-dependent

Exons were annotated manually according to AceView and FAST-DB databases. Column Headers: Gene ID, official gene symbol; Exon position, number of exon within the primary transcript; Gene Description; Localization, the sub-cellular fraction used for CLIP experiment; Gene Family; Function, the primary encoded function of gene. This table is a partial list of cassette exons bound by SF2/ASF. The complete list can be found in [Table S1](#pone.0003369.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0003369.t002

###### Annotated as described in [Table 1](#pone-0003369-t001){ref-type="table"}.

![](pone.0003369.t002){#pone-0003369-t002-2}

  *SF2/ASF target exons containing alternative 3′ splice sites*                                                                                                                                        
  --------------------------------------------------------------- ----- --------------------------------------------------------------------- ------------------------------ ------------------------- -----------------------------------------------------------------------
  PSAP                                                              7                                prosaposin                                          Nucleus                       other                    glycosphingolipid metabolic process; lipid transport
  HN1                                                               3                hematological and neurological expressed 1                          Nucleus                       other                                       Not Determined
  IGF1R                                                            21                   insulin-like growth factor 1 receptor                            Nucleus              transmembrane receptor                     insulin receptor signaling pathway
  PRELID1                                                           5                         PRELI domain containing 1                                  Nucleus                       other                            multicellular organismal development
  CALM2                                                             3                calmodulin 2 (phosphorylase kinase, delta)                         Cytoplasm                      other            Calcium Binding; G-protein coupled receptor protein signaling pathway
  AHCY                                                             10                     S-adenosylhomocysteine hydrolase                              Cytoplasm                     enzyme                            one-carbon compound metabolic process
  ZFP91                                                            11                  zinc finger protein 91 homolog (mouse)                           Cytoplasm             transcription regulator  
  UBE3B                                                            28                       ubiquitin protein ligase E3B                                Cytoplasm                     enzyme                                     Protein degredation
  RPL10A                                                            6                          ribosomal protein L10a                                   Cytoplasm                      other                                     Ribosome Component
  GK                                                               17                              glycerol kinase                                      Cytoplasm                     kinase           
  RPS10                                                             3                           ribosomal protein S10                               Nucleus; Cytoplasm                 other                                     Ribosome Component
  MGST3                                                             2                  microsomal glutathione S-transferase 3                       Nucleus; Cytoplasm                enzyme                        lipid metabolic process; signal transduction
  RPL19                                                             6                           ribosomal protein L19                               Nucleus; Cytoplasm                 other                                     Ribosome Component
  NAGPA                                                             5    N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucos-aminidase        Nucleus; Cytoplasm                enzyme            carbohydrate metabolic process; lysosome organization and biogenesis
  B2M                                                               2                           beta-2-microglobulin                                Nucleus; Cytoplasm        transmembrane receptor                               immune response
  ETNK1                                                             2                           ethanolamine kinase 1                              Cytoplasm; Polysome                kinase                       Phosphatidylethanol-amine biosynthetic process
  EEF1A1                                                           3,6           eukaryotic translation elongation factor 1 alpha 1            Nucleus; Cytoplasm; Polysome         translation                               translational elongation
  FLJ00313                                                          7                              Not Determined                                        Nucleus                      Unknown                                          Unknown
  NR2C1                                                            12              nuclear receptor subfamily 2, group C, member 1                       Nucleus              transcription regulator                                  Unknown
  PWP1                                                             13                       PWP1 homolog (S. cerevisiae)                                 Nucleus                       other                                           Unknown
  CENPO                                                             5                           centromere protein O                                     Nucleus                       other                          role in cell growth and/or transcription
  TCF12                                                             9                          transcription factor 12                                  Cytoplasm             transcription regulator             Regulation of transcription by RNA Polymerase II

10.1371/journal.pone.0003369.t003

###### Annotated as described in [Table 1](#pone-0003369-t001){ref-type="table"}.

![](pone.0003369.t003){#pone-0003369-t003-3}

  *SF2/ASF target exons containing alternative 5′ splice sites*                                                                                                                                         
  --------------------------------------------------------------- ------- -------------------------------------------------------------------- ------------------------------ ------------------------- ----------------------------------------------------------------------
  NAGPA                                                              5     N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase        Nucleus; Cytoplasm                enzyme            carbohydrate metabolic process; lysosome organization and biogenesis
  SERBP1                                                             6                      SERPINE1 mRNA binding protein 1                               Nucleus                       other                                      mRNA processing
  CDK4                                                               2                         cyclin-dependent kinase 4                                  Nucleus                      kinase                                   Cell Cycle Regulation
  CDC14A                                                            15           CDC14 cell division cycle 14 homolog A (S. cerevisiae)                   Nucleus                    phosphatase                    dual specificity protein tyrosine phosphatase
  BCOR                                                               4                             BCL6 co-repressor                                     Cytoplasm             transcription regulator                       Transcriptional corepressor
  RPL5                                                               1                            ribosomal protein L5                                   Cytoplasm                      other                                     Ribosome Component
  NOL1                                                              16                        nucleolar protein 1, 120kDa                                 Polysome                      other                        Cell Cycle Regulation; RNA Methyltransferase
  PKM2                                                               2                          pyruvate kinase, muscle                             Cytoplasm; Polysome                kinase                                     Glycolytic enzyme
  ETNK1                                                              2                           ethanolamine kinase 1                              Cytoplasm; Polysome                kinase                       phosphatidylethanolamine biosynthetic process
  MAPK3                                                              6                     mitogen-activated protein kinase 3                            Cytoplasm                     kinase                              intracellular signaling cascade
  EEF1A1                                                           2,3,6           eukaryotic translation elongation factor 1 alpha 1           Nucleus; Cytoplasm; Polysome         translation                               translational elongation

10.1371/journal.pone.0003369.t004

###### Annotated as described in [Table 1](#pone-0003369-t001){ref-type="table"}.

![](pone.0003369.t004){#pone-0003369-t004-4}

  *SF2/ASF target exons containing a retained intron*                                                                                                                                                        
  ----------------------------------------------------- ---- ---------------------------------------------------------------------------------------- ------------------------------ ----------------------- ----------------------------------------------------------------------
  ATP5B                                                  2          ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide               Nucleus; Cytoplasm             transporter                   generation of precursor metabolites and energy
  ATP7B                                                  2                         ATPase, Cu++ transporting, beta polypeptide                                   Nucleus                   transporter                          cellular copper ion homeostasis
  EEF1A1                                                 1                      eukaryotic translation elongation factor 1 alpha 1                     Nucleus; Cytoplasm; Polysome   translation regulator                         translational elongation
  GNL3                                                   13                   guanine nucleotide binding protein-like 3 (nucleolar)                             Cytoplasm                     other                                 Stem Cell Proliferation
  NAGPA                                                  5              N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase                  Nucleus; Cytoplasm               enzyme           carbohydrate metabolic process; lysosome organization and biogenesis
  RAN                                                    7                               RAN, member RAS oncogene family                                         Nucleus                     enzyme               GTP-binding protein involved in nucleocytoplasmic transport
  RPL12                                                  7                                    ribosomal protein L12                                              Nucleus                      other                                    Ribosome Component
  RPL23                                                  3                                    ribosomal protein L23                                              Polysome                     other                                    Ribosome Component
  RPLP0                                                  5                                 ribosomal protein, large, P0                                          Nucleus                      other                                    Ribosome Component
  SFRS1                                                  4    splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)            Cytoplasm                     other                                     mRNA processing
  TH1L                                                   15                                   TH1-like (Drosophila)                                             Cytoplasm                     other                                 Transcription regulator
  TSSC4                                                  4                        tumor suppressing subtransferable candidate 4                                  Nucleus                      other                                         Unknown
  WDR59                                                  12                                    WD repeat domain 59                                               Nucleus                   transporter                                   Not Determined
  ZMYM3                                                  7                                   zinc finger, MYM-type 3                                            Cytoplasm                     other                           multicellular organismal development

10.1371/journal.pone.0003369.t005

###### Annotated as described in [Table 1](#pone-0003369-t001){ref-type="table"}.

![](pone.0003369.t005){#pone-0003369-t005-5}

  *SF2/ASF target exons located adjacent to alternative cassette exons*                                                                                                                                               
  ----------------------------------------------------------------------- ---- ----------------------------------------------------------------------------------------- -------------------- ----------------------- --------------------------------
  NETO2                                                                    9                           neuropilin (NRP) and tolloid (TLL)-like 2                              Cytoplasm        Transmembrane Protein   development; neuronal function
  PRKRA                                                                    4         protein kinase, interferon-inducible double stranded RNA dependent activator             Cytoplasm               Kinase                   Pro-apoptosis
  RPS24                                                                    6                                     ribosomal protein S24                                        Cytoplasm         Ribosome Component           Translation factor
  PABPC1                                                                   12                           poly(A) binding protein, cytoplasmic 1                            Nucleus; Polysome            Other               translation regulator
  BRD2                                                                     13                                  bromodomain containing 2                                        Nucleus                kinase             generation of spermatozoa
  YWHAH                                                                    2    tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide   Nucleus; Cytoplasm           Other              transcription regulator
  HNRPDL                                                                   9                        heterogeneous nuclear ribonucleoprotein D-like                             Nucleus                 Other                  mRNA processing
  HNRPAB                                                                   8                          heterogeneous nuclear ribonucleoprotein A/B                              Nucleus                 Other                  mRNA processing
  MPZL1                                                                    6                                  myelin protein zero-like 1                                  Nucleus; Cytoplasm   Transmembrane Protein              Receptor

Regulation of endogenous nuclear and cytoplasmic mRNA processing by SF2/ASF {#s2e}
---------------------------------------------------------------------------

A majority of RNA fragments that co-purified with SF2/ASF contain a purine-rich consensus motif, reminiscent of previous SELEX binding sites [@pone.0003369-Tacke1]. Interestingly, a subset of mRNA targets was bound by SF2/ASF in both the nucleus and the cytoplasm. Three of these targets, ENSA (endosulfine α), PABPC1 (poly A binding protein 1) and NETO2 (neuropillin-like tolloid receptor 2) contained binding sites for SF2/ASF within or flanking alternative cassette exons, whereas the SFRS1 (pre-mRNA encoding SF2/ASF) contains a binding site adjacent to a retained intron. We then asked whether SF2/ASF modulates the alternative splicing of these pre-mRNAs in the nucleus and enhance their translation in the cytoplasm. We manipulated the levels of SF2/ASF in HEK293T cells by transfecting cells with siRNA targeting endogenous SF2/ASF, scrambled control siRNA or plasmid to increase levels of SF2/ASF by transient ectopic expression and assayed alternative splicing of endogenous ENSA, SF2/ASF, PABP and NETO2. [Fig. 4A](#pone-0003369-g004){ref-type="fig"} shows a Western blot from control cells (lanes 1,2, and 4, respectively) or cells depleted or over expressing SF2/ASF (lanes 3 and 5, respectively). In the context of the ENSA pre-mRNA, the observed binding site is located within an alternative cassette exon. As expected ectopic expression of SF2/ASF increases inclusion of the alternative exon, relative to the cells depleted for SF2/ASF ([Fig. 4B](#pone-0003369-g004){ref-type="fig"}). Binding sites for SF2/ASF within the PABP and Neto2 pre-mRNAs are in exons proximal to alternative cassette exons. We found that ectopic expression of SF2/ASF causes increased skipping of the alternative cassette exon in both cases ([Fig. 4B](#pone-0003369-g004){ref-type="fig"}). Finally, the observed binding site for SF2/ASF within its\' own pre-mRNA (transcribed from the SFRS1 gene) is located near an ultra-conserved element adjacent to a retained intron within the 3′UTR [@pone.0003369-Lareau1], [@pone.0003369-Ni1]. This intron is believed to attenuate expression of the SFRS1 gene through regulated unproductive splicing and translation (RUST) mechanism [@pone.0003369-Lareau1]. We observe that ectopic expression of SF2/ASF increase splicing of this intron and provides supporting evidence for the RUST hypothesis ([Fig. 4B](#pone-0003369-g004){ref-type="fig"}).

![Alternative splicing of endogenous RNA transcripts targeted by SF2/ASF.\
A) Western blot analysis of HEK293T cells co-transfected with siRNA duplexes and expression plasmids. The upper panel is probed with anti-SF2/ASF monoclonal antibody, the lower panel is probed with anti-GAPDH monoclonal antibody. Lane 1, non transfected control (NTC); Lane 2, Mock (no siRNA or plasmid); Lane 3, siRNA targeting SF2/ASF and empty vector (pCGT7); Lane 4, scrambled siRNA and empty vector; Lane 5, scrambled siRNA and T7-tagged SF2/ASF expression plasmid (pCGT7 SF2). Total RNA was purified for RT-PCR analysis from samples corresponding to lanes 3 and 5. B) RT-PCR analysis of alternative splicing. Radiolabeled products were visualized by phosphorimaging. Schematic diagrams show exon-intron structure of target genes and patterns of alternative splicing. Thin rectangles indicate untranslated regions, thick rectangles indicate coding regions, thick lines indicate introns and thin lines indicate the alternative splicing event. Exons identified by CLIP are yellow. The grey region in the SFRS1 3′UTR indicates a retained intron. Arrowheads to the left of each panel indicate the included (gray arrowhead) and skipped (black arrowhead) alternative mRNA isoform. Lane 1 and 2 contain RNA purified from SF2/ASF overexpressing and depleted cells, for example see panel A, lanes 5 and 3, respectively. The sub-cellular fraction corresponding to the initial CLIP experiment is indicated below each gene symbol.](pone.0003369.g004){#pone-0003369-g004}

The splicing of each of these endogenous pre-mRNA targets is effected by increasing the intracellular concentrations of SF2/ASF. It is known that SF2/ASF can remain associated with mRNA following the splicing reaction and that SF2/ASF can enhance the translation of reporter mRNAs [@pone.0003369-Sanford1], [@pone.0003369-Sanford2]. The CLIP method revealed that a subset of SF2/ASF mRNA targets, including PABP, NETO2, ENSA and SFRS1, were bound by SF2/ASF in the cytoplasm of HEK293T cells. This observation suggests that SF2/ASF may also enhance the translation of these particular mRNA targets. To test this hypothesis we asked whether a specific mRNA target of SF2/ASF exhibited increased association with polyribosomes, the actively translating pool of ribosomes, when SF2/ASF is overexpressed. Cytoplasmic extracts were prepared from HEK293T cells transfected with empty expression vector or epitope tagged SF2/ASF ([Fig. 5A](#pone-0003369-g005){ref-type="fig"}). Cytoplasmic extracts were resolved across 10--45% sucrose gradients. Following fractionation, total RNA was extracted from every other fraction and cDNA was synthesized using oligo dT primer. Upon ectopic expression of SF2/ASF all four endogenous mRNA targets showed increased association with polyribosomes ([Fig. 5A, lanes 5--8](#pone-0003369-g005){ref-type="fig"}). By contrast, levels of GAPDH remain constant across the gradient when SF2/ASF is overexpressed. We also examined the distribution of several other endogenous targets, but found no difference when SF2/ASF is over expressed, suggesting that this effect is specific for a subset of transcripts rather than a global phenomenon (data not shown). Additionally, there are no obvious differences between the distributions of total RNA across the gradient. These data are in good agreement with our previous findings that SF2/ASF can enhance the polysome association and translation of luciferase reporter mRNAs both *in vitro* and *in vivo* [@pone.0003369-Sanford1]--[@pone.0003369-Michlewski1]. Finally these data provide clear evidence that SF2/ASF can drive enhaced polysome association of endogenous mRNAs *in vivo*.

![Polyribosome association of endogenous SF2/ASF mRNA targets.\
A) Western blot analysis of cytoplasmic extracts prepared from cells transfected with pCGT7 of pCGT7 SF2/ASF (lanes 1 and 2, respectively). Blots were probed with anti-SF2/ASF and anti-GAPDH (left and right panel, respectively). B) Polyribosome association of endogenous mRNAs. Cytoplasmic extracts from control or pCGT7 SF2/ASF cells were resolved by sucrose gradient fractionation. The upper panel shows the absorbance of rRNA across the gradient, the positions of ribosomal subunits and complexes are indicated. Lower panels: RT-PCR analysis of RNA targets. Products were resolved by agarose gel electrophoresis. The sub-cellular fraction corresponding to the initial CLIP experiment is indicated below each gene symbol.](pone.0003369.g005){#pone-0003369-g005}

Discussion {#s3}
==========

SF2/ASF is a nucleo-cytoplasmic shuttling RNA binding protein with clearly defined activities in spliceosome assembly. Our previous work established a role for SF2/ASF in mRNA translation [@pone.0003369-Sanford1], [@pone.0003369-Sanford2]. These findings suggested that SF2/ASF may co-ordinate the nuclear and cytoplasmic steps of post-transcriptional gene expression for a subset of pre-mRNAs. This hypothesis is further supported by the observation that extrinsic signals leading to activation of the AKT protein kinase enhance the alternative splicing and translation of reporter RNAs containing a consensus SF2/ASF binding site [@pone.0003369-Blaustein1]. We used the CLIP protocol to extend our findings to endogenous cellular mRNAs. CLIP allowed us to sample direct mRNA targets of SF2/ASF under conditions that preserve the *in situ* specificity of protein-RNA interactions. By coupling CLIP with sub-cellular fractionation we were able to identify mRNAs associated with SF2/ASF in the nucleus, cytoplasm and in the actively translating pool of ribosomes ([Fig. 2](#pone-0003369-g002){ref-type="fig"} and [Table S1](#pone.0003369.s001){ref-type="supplementary-material"}). These data revealed a set of mRNAs whose splicing and translation may be coordinated by SF2/ASF. Collectively, our data do not support the view that SF2/ASF plays a general role in mRNA translation, but suggests that the biological importance of this aspect of SF2/ASF function may be at transcript and cell types-specific events. Our recent findings that mTOR is critical to translational control by SF2/ASF suggest that SF2/ASF may connect cellular signal transduction pathways with post-transcriptional control of specific target mRNAs [@pone.0003369-Michlewski1].

Using the CLIP approach we were able to not only identify potential RNA targets for SF2/ASF but also define a consensus binding motif present in exonic binding sites ([Fig. 3](#pone-0003369-g003){ref-type="fig"}). This purine-rich motif closely resembles the well-characterized exonic splicing enhancers (ESE) present in the fibronectin EDA alternative cassette exon as well as exon 5 of the cardiac troponin T (cTNT) gene [@pone.0003369-Caputi1], [@pone.0003369-Ramchatesingh1]. The binding specificity of SR proteins has also been extensively studied using SELEX strategies. Our data are in good agreement from results obtained using only the RRM domains of SF2/ASF for *in vitro* evolution of binding sites [@pone.0003369-Tacke1]. By contrast, functional SELEX experiments, in which bona fide ESEs within reporter constructs are replaced by randomized sequence and *in vitro* splicing is driven by a single recombinant SR protein in S100 complementation assays, yielded different consensus motifs for SF2/ASF [@pone.0003369-Smith1]. The functional SELEX motifs are more heterogeneous in nature but may represent binding sites for SF2/ASF that can lead to productive splicing. The differences between motifs identified by functional SELEX and CLIP may reflect inherent differences in the experimental conditions. For example, photo cross-linking of protein-RNA interactions is believed to be fairly inefficient, but it allows for recovery of sequences under stringent conditions. It remains possible that sequences identified by CLIP represent only a subset of possible binding sites that are both abundant and suitable for cross-linking. Data presented in [Fig. 4B](#pone-0003369-g004){ref-type="fig"} demonstrates that SF2/ASF can regulate the alternative splicing of a subset of pre-mRNAs suggesting that the observed binding sites are functionally relevant. Indeed, 26 out of 44 endogenous pre-mRNAs containing binding sites for SF2/ASF within or proximal to cassette exons appear to be functionally relevant when tested by RT-PCR ([Fig. 4B](#pone-0003369-g004){ref-type="fig"} and data not shown). Thus we feel the CLIP method has captured a subset of biologically relevant SF2/ASF binding sites.

Cataloguing the collection of *cis*-acting elements directing post-transcriptional gene regulation on a global scale is only at the initial stages of investigation. *In silico* studies have successfully elucidated *cis*-acting elements that are enriched or co-evolve with constitutive and alternative exons. Several recent computational screens have defined thousands of hexa- or octamers as splicing regulatory sequences [@pone.0003369-Yeo1]--[@pone.0003369-Zhang1]. If a combinatorial code governing splice site selection exists, the solution will likely emerge through interdisciplinary approaches merging computational methods with biochemical and functional genomics approaches. Methods such as SELEX, CLIP and RIP-Chip have the potential to illuminate the specificity and functions of RNA binding proteins by making connections between trans-acting RNA binding proteins and the biological processes they regulate [@pone.0003369-Ule2], [@pone.0003369-Hieronymus1]--[@pone.0003369-Zhang2]. CLIP also provides the added value of determining potential mechanisms of RNA binding protein action by revealing the positional context of *cis*-acting RNA elements within a transcript [@pone.0003369-Ule2]. RNA binding protein target specificity can also be evaluated using platforms to profile alternative splicing such as exon tiling arrays, spliced junction array platforms and RNA-Seq [@pone.0003369-Clark1]--[@pone.0003369-Nagalakshmi1]. Discrimination of direct versus indirect effects is a limitation of these experiments however this may be overcome by applying computational models of consensus binding sites generated by CLIP or SELEX to classify global changes in alternative splicing [@pone.0003369-Blanchette1], [@pone.0003369-Olson1]. Our initial CLIP experiment with SF2/ASF revealed just a small snap shot of putative RNA targets. One clear limitation of this study is the inefficiency of the Sanger sequencing. Merging CLIP with high throughput genome wide sequencing platforms such as Solexa and 454 (Illumina, USA and Roche Diagnostics, USA, respectively), will vastly expand our ability to define the RNA binding specificity. These data will allow for a high resolution map of SF2/ASF binding sites that not only illuminate mechanisms of action in pre-mRNA splicing but also reveal connections to important biological processes such as genome stability, cellular transformation and non-coding RNA processing.

Materials and Methods {#s4}
=====================

Cell culture and transient transfection {#s4a}
---------------------------------------

For CLIP analysis of SF2/ASF, HEK293T cells were grown to 75--80% confluence at 37°C, 5% CO~2~. HEK293T cells were cultured in DMEM containing 10% Fetal Calf Serum and antibiotics. Transient transfection of HEK293T cells with plasmid DNA was performed using Lipofectamine 2000 (Invitrogen) following the manufacturers instructions. Transient transfection of siRNA duplexes and plasmid DNA were performed using Duo-fect transfection reagent (Dharmacon) following the manufacturers specifications. Cells were harvested 48 hours following transfection. siRNA transfection efficiency was monitored using siGLO green siRNA duplexes (Dharmacon) and was found to be 80--95% efficient.

Plasmids and siRNA {#s4b}
------------------

T7 Epitope tagged SF2/ASF was expressed from the pCGT7 vector and has been described previously [@pone.0003369-Cazalla1]. siRNA *Smartpools* targeting the endogenous SF2/ASF transcript, or scrambled nontargeting siRNA duplexes were purchased from Dharmacon.

Cross-linking Immunoprecipitation of SF2/ASF from HEK293T cells {#s4c}
---------------------------------------------------------------

CLIP analysis of SF2/ASF was performed as described by Ule et al.[@pone.0003369-Yeo1] with the following modifications relating to extract preparation and RNase treatment. Nuclear and cytoplasmic extracts were prepared from UV-treated or control cells as previously described [@pone.0003369-Sanford1]. The soluble extract was treated with 30 U RQ DNase 1 for 20 min at 37°C. The reactions were terminated by the addition of 20 mM EDTA. Subsequently, ribosomal subunits were cleared by centrifugation of the extract at 100,000× g using an Optima Max ultracentrifuge (Beckman Coulter, USA) in a TLA120.2 rotor for 20 min. Cleared extracts were then treated with a dilute cocktail of RNase A/T1 (Ambion, USA) at a final dilution range of 1∶1000--1∶10,000 for 20 min at 37°C. 200 U RNaseOut (Invitrogen, USA) was then added to the extract. Proteins were then partially denatured by addition of an equal volume of buffer A (2× PBS, 0.2% SDS, 1% NP-40). An aliquot of each UV-treated extract was used to prepare input RNA fragments. The remainder of the extract was used for immunoprecipitation with anti-SFRS1 monoclonal antibody.

Characterization of the CLIP tags {#s4d}
---------------------------------

All Human exon and gene information was downloaded from Ensembl, using the BioMart tool. The sequence data was downloaded using Perl scripts to access the ensembl database through the Ensembl Core Perl API. The CLIPS sequences were mapped against unspliced gene, cDNA and coding sequences using Mega BLAST (Zhang et al. 2000). The unambiguous mapping of the CLIP tags allowed us to match the CLIPs to Ensembl gene ids. The characterization of type of splicing event that occurs on the alternatively spliced exons that were found to be bound by SF2/ASF was performed according to Ensembl exon information.

Identification of the SF2/ASF binding site {#s4e}
------------------------------------------

The distinct CLIP tags that match exons were used on the MEME (Bailey et al., 2006) web server (<http://meme.sdsc.edu/meme/meme.html>) to identify patterns that are probabilistically significant. The intronic set of CLIP tags was used in the same way but did not result in any meaningful pattern.

The genome wide distribution of the SF2/ASF binding site pattern {#s4f}
----------------------------------------------------------------

To identify the genome-wide distribution of SF2/ASF binding sites around exon splice sites, for each exon from a protein coding gene (greater than 100 bp), we generated a composite sequence made of the 75 bp upstream of the 3′ splice site, the 5′ exonic 25 bp, the 50 bp from the middle of the exon, the 25 bp 3′ exonic and 75 bp downstream of the 5′ splice site. There were in total 174,440 exons that satisfied this criteria. These were then analyzed using the binding sites in CLIP tags that were identified by MEME.

Parsing of Data {#s4g}
---------------

All parsing of data was performed using multiple Perl scripts.

*in vivo* splicing assay {#s4h}
------------------------

HEK293T cells were transfected as described above. Cells were harvested 48 hours post-transfection. One aliquot was used for western blot analysis the other was used to prepare total RNA from the cytosolic fraction. RNA was extracted using TRI Reagent LS (Sigma) following the manufacturers instructions. cDNA was synthesized using oligo dT primer and Superscript RT III (Invitrogen). 50 ng of cDNA was used as a template for RT-PCR analysis. Primers were 5′ end labelled with ^32^PγATP and T4 PNK (NEW England Biolabs). Primers are available upon request. PCR was performed using the following conditions: 3 min at 94°C; 30 cycles of 94°C 30 sec, 59°C 30 sec, 72°C 60 sec; 72°C 5 min. Following PCR, the reactions were ethanol precipitated and resolved upon 10% polyacrylamide/7M urea gels. RT-PCR reactions were visualized by autoradiography or phosphorimager.

Polyribosome Profiles {#s4i}
---------------------

Polyribosome profiles were obtained from HEK293T cells as previously described [@pone.0003369-Sanford1], [@pone.0003369-Sanford2]. Total RNA was extracted from each fraction using TRI Reagent LS. Every other fraction was analyzed by RT-PCR. Purification of polyribosome for CLIP analysis of SF2/ASF was accomplished by pelleting polyribosomes through 10--25% sucrose gradients as previously described [@pone.0003369-Sanford2]. Polysome pellets were washed gently with cold PBS, then resuspended in cold 0.5× buffer A (see above). The polysomes were then treated with RQ DNase, and RNase as described in the CLIP protocol [@pone.0003369-Ule1].

Supporting Information {#s4j}
----------------------

A supplementary excel spread sheet accompanies this manuscript ([Table S1](#pone.0003369.s001){ref-type="supplementary-material"}). It contains complete annotation of the CLIP data.

Supporting Information {#s5}
======================

###### 

A complete list of binding site annotation using the Ensembl, UCSC Known Gene and Rfam databases. The Excel file can be filtered in order to find binding sites identified by CLIP using nuclear, cytoplasmic or polysomal extracts. Headers for the table are as follows: Chromosome: Defines the specific chromosome from the human genome to which the seq-block mapped. Strand: CLIP preserves the orientation of the captured RNA marker, so that it is possible to determine the strandedness of the locus. Id: Generic description given to each binding site during our annotation work flow. Region start/end: The precise chromosomal coordinates defining the unique or overlapping sequence blocks. Regions are define by at least 2 partially overlapping binding sites mapping to the locus. \# of fragments in the Cytoplasm/Nucleus/Polysome indicates if the binding site was identified in each compartment. The number specifies whether a sequence block was absent, present in a single assay or multiple assays. \# of sample targets is useful for finding binding sites that are in 1, 2 or all three cellular fractions. Gene Annotation: This column describes the relationship of the seq block to annotated protein coding genes based on the UCSC Known Gene Database. Exon Style: This column describes the relationship of the seq block to annotated parts of protein coding genes (exon, intron etc). The strategy is presented in Supplementary [Figure 2](#pone-0003369-g002){ref-type="fig"}. USCS Known Gene database ID: This column refers to the name of a specific gene cluster by the UCSC Known Gene database. Gene Symbol: This column contains information pertaining to the approved HUGO Gene Nomenclature Committee symbol for each protein coding gene. Exon Position: This column describes the position of the exon within the protein coding gene. First/Last exon columns: Designation of "1" in either column indicates 5′ or 3′ terminal exon. "1" in both columns denotes that the sequence block is in a single exon gene. Upstream/Downstream Exon Position: These columns are useful for determining the position of introns within a protein coding gene. ncRNA Annotation: Describes the relationship of a sequence block to annotated non coding RNA (ncRNA). Annotation is based on the Rfam database. ncRNA Name: This column describes the gene symbol for each ncRNA containing a sequence block. UTR type: Describes the relationship between sequence blocks and untranslated regions of protein coding genes. Splicing Event: Gives alternative splicing annotation for exonic binding sites based upon AceVIEW, ALT Events and Fast-db, databases.

(0.13 MB XLS)

###### 

Click here for additional data file.
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